Home › Companies › MEDPACE HOLDINGS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and MEDPACE HOLDINGS INC.’s Form 8-K, filed May 21, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 17, 2024: 5 items on MEDPACE HOLDINGS INC.’s Form 8-K, filed May 21, 2024: 2 elected · 3 approved.
Significant dissent: 2 directors (39.0%, 30.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore MEDPACE HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are MEDPACE HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Fred B. Davenport, Jr. | 16,532,146 | -- | -- | 10,556,096 | 1,646,311 | 61% | Elected | — |
| Elect Director: Cornelius P. McCarthy III | 18,826,983 | -- | -- | 8,261,259 | 1,646,311 | 70% | Elected | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 27,926,739 | 800,797 | 7,017 | -- | -- | 97% | Approved | — |
| 3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers | 26,373,187 | 701,630 | 13,425 | -- | 1,646,311 | 97% | Approved | — |
| 4. Amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually | 27,081,976 | 4,407 | 1,859 | -- | 1,646,311 | 99.9% | Approved | — |
Source: MEDPACE HOLDINGS INC., Form 8-K, filed with the SEC on May 21, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
532 asset managers disclosed a vote on at least one MEDPACE HOLDINGS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
61% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Fred B. Davenport, Jr.
MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Fred B. Davenport, Jr.”): 16,532,146 for, 10,556,096 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class II Directors until the Company's 2027 Annual Meeting of Stockholders based upon the following votes:”
Support: 61% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 129 asset managers below reported 6,232,430 for, 3,123 against, 3,694,400 withheld, 369,191 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,815,157 | 0 | 0 | 51,818 | For |
| BlackRock | 0 | 0 | 0 | 1,472,113 | Withhold |
| Fidelity | 717,725 | 0 | 0 | 28,394 | For |
| Invesco | 702,479 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 513,814 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 0 | 298,993 | Withhold |
| Dimensional | 0 | 0 | 0 | 237,879 | Withhold |
| Charles Schwab | 201,730 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 194,643 | Withhold |
| Goldman Sachs | 1,579 | 0 | 0 | 151,358 | Withhold |
| State Street | 66 | 0 | 0 | 147,753 | Withhold |
| John Hancock | 104,903 | 0 | 28,012 | 0 | Mixed |
| Prudential/PGIM | 132,163 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 120,457 | Withhold |
| CARILLON SERIES TRUST | 8,783 | 0 | 111,635 | 0 | Mixed |
| First Trust | 0 | 0 | 0 | 119,143 | Withhold |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 107,780 | Withhold |
| Putnam | 107,191 | 0 | 0 | 0 | For |
| Legg Mason | 100,116 | 0 | 0 | 3,458 | For |
| TIAA | 99,126 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 92,458 | 0 | Abstain |
| Columbia Threadneedle | 88,836 | 0 | 0 | 0 | For |
| JPMorgan | 87,761 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 82,304 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 59,296 | 0 | 0 | 0 | For |
Showing the 25 largest of 129 asset managers. All 129 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Cornelius P. McCarthy III
MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Cornelius P. McCarthy III”): 18,826,983 for, 8,261,259 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class II Directors until the Company's 2027 Annual Meeting of Stockholders based upon the following votes:”
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 128 asset managers below reported 7,776,157 for, 3,123 against, 2,162,503 withheld, 355,561 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,815,157 | 0 | 0 | 51,818 | For |
| BlackRock | 1,472,113 | 0 | 0 | 0 | For |
| Fidelity | 734,519 | 0 | 0 | 11,600 | For |
| Invesco | 702,479 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 513,814 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 0 | 298,993 | Withhold |
| Dimensional | 0 | 0 | 0 | 237,879 | Withhold |
| Charles Schwab | 201,730 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 194,643 | Withhold |
| Goldman Sachs | 1,579 | 0 | 0 | 151,358 | Withhold |
| State Street | 66 | 0 | 0 | 147,753 | Withhold |
| John Hancock | 104,903 | 0 | 28,012 | 0 | Mixed |
| Prudential/PGIM | 132,163 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 120,457 | Withhold |
| CARILLON SERIES TRUST | 8,783 | 0 | 111,635 | 0 | Mixed |
| First Trust | 0 | 0 | 0 | 119,143 | Withhold |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 107,780 | Withhold |
| Putnam | 107,191 | 0 | 0 | 0 | For |
| Legg Mason | 100,116 | 0 | 0 | 3,458 | For |
| TIAA | 99,126 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 92,458 | 0 | Abstain |
| Columbia Threadneedle | 88,836 | 0 | 0 | 0 | For |
| JPMorgan | 87,761 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 82,304 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 59,296 | 0 | 0 | 0 | For |
Showing the 25 largest of 128 asset managers. All 128 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually.
MEDPACE HOLDINGS INC.’s own tally for this item (“4. Amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of S”): 27,081,976 for, 4,407 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal to amend the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually was approved based upon the followin…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 134 asset managers below reported 10,026,401 for, 1,511 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,866,975 | 0 | 0 | 0 | For |
| BlackRock | 1,472,113 | 0 | 0 | 0 | For |
| Fidelity | 746,119 | 0 | 0 | 0 | For |
| Invesco | 702,479 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 513,814 | 0 | 0 | 0 | For |
| Dimensional | 237,879 | 0 | 0 | 0 | For |
| Charles Schwab | 201,730 | 0 | 0 | 0 | For |
| T. Rowe Price | 194,643 | 0 | 0 | 0 | For |
| Goldman Sachs | 152,937 | 0 | 0 | 0 | For |
| State Street | 147,819 | 0 | 0 | 0 | For |
| John Hancock | 132,915 | 0 | 0 | 0 | For |
| Prudential/PGIM | 132,163 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 120,457 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 120,418 | 0 | 0 | 0 | For |
| First Trust | 119,143 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 107,780 | 0 | 0 | 0 | For |
| Putnam | 107,191 | 0 | 0 | 0 | For |
| Legg Mason | 103,574 | 0 | 0 | 0 | For |
| TIAA | 99,126 | 0 | 0 | 0 | For |
| Loomis Sayles | 92,458 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 88,836 | 0 | 0 | 0 | For |
| JPMorgan | 87,761 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 82,304 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 59,296 | 0 | 0 | 0 | For |
| Jackson National | 58,498 | 0 | 0 | 0 | For |
Showing the 25 largest of 134 asset managers. All 134 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.
MEDPACE HOLDINGS INC.’s own tally for this item (“3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers”): 26,373,187 for, 701,630 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 — Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of MEDPACE HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (24 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Section 14a Executive Compensation” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “To approve, on an advisory basis, the H of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.” (2 managers, 15,420 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,866,975 | 0 | 0 | 0 | For |
| BlackRock | 1,472,113 | 0 | 0 | 0 | For |
| Fidelity | 746,119 | 0 | 0 | 0 | For |
| Invesco | 702,479 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 513,814 | 0 | 0 | 0 | For |
| Dimensional | 237,879 | 0 | 0 | 0 | For |
| Charles Schwab | 201,730 | 0 | 0 | 0 | For |
| T. Rowe Price | 194,643 | 0 | 0 | 0 | For |
| Goldman Sachs | 152,937 | 0 | 0 | 0 | For |
| State Street | 147,819 | 0 | 0 | 0 | For |
| John Hancock | 132,915 | 0 | 0 | 0 | For |
| Prudential/PGIM | 132,163 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 120,457 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 120,418 | 0 | 0 | 0 | For |
| First Trust | 119,143 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 107,780 | 0 | 0 | 0 | For |
| Putnam | 107,191 | 0 | 0 | 0 | For |
| Legg Mason | 103,574 | 0 | 0 | 0 | For |
| TIAA | 99,126 | 0 | 0 | 0 | For |
| Loomis Sayles | 92,458 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 88,836 | 0 | 0 | 0 | For |
| JPMorgan | 87,761 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 82,304 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 59,296 | 0 | 0 | 0 | For |
| Jackson National | 58,498 | 0 | 0 | 0 | For |
Fund voting reports, all 132 managers: 10,005,180 for, 1,247 against, 5,608 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OAK RIDGE INVESTMENTS LLC | 10,000,000 | 0 | 0 | 0 | For |
| BlackRock | 839,844 | 0 | 0 | 0 | For |
| Invesco | 773,634 | 0 | 0 | 0 | For |
| WASATCH ADVISORS LP | 696,203 | 0 | 0 | 0 | For |
| State Street | 629,955 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 520,155 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 514,210 | 0 | 0 | Against |
| RIVERBRIDGE PARTNERS LLC | 484,156 | 0 | 0 | 0 | For |
| BESSEMER TRUST Co NATIONAL ASSOCIATION | 457,240 | 0 | 0 | 0 | For |
| Epoch Investment Partners, Inc. | 380,042 | 0 | 0 | 0 | For |
| Bessemer Trust CO of Delaware, N.A. | 319,280 | 0 | 0 | 0 | For |
| Wellington | 316,295 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 313,469 | 0 | 0 | 0 | For |
| BESSEMER TRUST Co OF FLORIDA | 312,835 | 0 | 0 | 0 | For |
| DE Shaw | 279,426 | 0 | 0 | 0 | For |
| BESSEMER TRUST CO | 276,264 | 0 | 0 | 0 | For |
| Bessemer Trust Co of California, N.A. | 266,553 | 0 | 0 | 0 | For |
| Bessemer Trust Co of Nevada, National Association | 266,116 | 0 | 0 | 0 | For |
| T. Rowe Price | 264,976 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 244,087 | 0 | 0 | 0 | For |
| Fidelity | 215,410 | 0 | 0 | 0 | For |
| Northern Trust | 207,354 | 0 | 0 | 0 | For |
| Charles Schwab | 203,574 | 0 | 0 | 0 | For |
| EAGLE ASSET MANAGEMENT INC | 201,173 | 0 | 0 | 0 | For |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 188,641 | 0 | 0 | 0 | For |
Institutional-manager reports, all 398 managers: 24,376,572 for, 950,034 against, 697 not voted, 519 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
MEDPACE HOLDINGS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December ”): 27,926,739 for, 800,797 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 138 asset managers below reported 10,340,129 for, 18,542 against, 5,608 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,866,975 | 0 | 0 | 0 | For |
| BlackRock | 1,472,113 | 0 | 0 | 0 | For |
| Fidelity | 746,119 | 0 | 0 | 0 | For |
| Invesco | 702,479 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 513,814 | 0 | 0 | 0 | For |
| Capitol Series Trust | 298,993 | 0 | 0 | 0 | For |
| Dimensional | 237,879 | 0 | 0 | 0 | For |
| Charles Schwab | 201,730 | 0 | 0 | 0 | For |
| T. Rowe Price | 194,643 | 0 | 0 | 0 | For |
| Goldman Sachs | 152,937 | 0 | 0 | 0 | For |
| State Street | 147,801 | 18 | 0 | 0 | For |
| John Hancock | 132,915 | 0 | 0 | 0 | For |
| Prudential/PGIM | 132,163 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 120,457 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 120,418 | 0 | 0 | 0 | For |
| First Trust | 119,143 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 107,780 | 0 | 0 | 0 | For |
| Putnam | 107,191 | 0 | 0 | 0 | For |
| Legg Mason | 103,574 | 0 | 0 | 0 | For |
| TIAA | 99,126 | 0 | 0 | 0 | For |
| Loomis Sayles | 92,458 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 88,836 | 0 | 0 | 0 | For |
| JPMorgan | 87,761 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 82,304 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 59,296 | 0 | 0 | 0 | For |
Showing the 25 largest of 138 asset managers. All 138 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 30,983,185 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.25% |
| 2 | BlackRock | 4.75% |
| 3 | Fidelity | 2.41% |
| 4 | Invesco | 2.27% |
| 5 | WASATCH FUNDS TRUST | 1.66% |
| 6 | Capitol Series Trust | 0.97% |
| 7 | Dimensional | 0.77% |
| 8 | Charles Schwab | 0.65% |
| 9 | T. Rowe Price | 0.63% |
| 10 | Goldman Sachs | 0.49% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | OAK RIDGE INVESTMENTS LLC | 32.28% |
| 2 | BlackRock | 2.71% |
| 3 | Invesco | 2.50% |
| 4 | WASATCH ADVISORS LP | 2.25% |
| 5 | State Street | 2.03% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.68% |
| 7 | Man Group plc | 1.66% |
| 8 | RIVERBRIDGE PARTNERS LLC | 1.56% |
| 9 | BESSEMER TRUST Co NATIONAL ASSOCIATION | 1.48% |
| 10 | Epoch Investment Partners, Inc. | 1.23% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| August J. Troendle | 6,046,852 | 19.52% | Proxy statement (DEF 14A), proxy filed April 3, 2024 |
| Medpace Investors, LLC | 4,733,019 | 15.28% | Proxy statement (DEF 14A), proxy filed April 3, 2024 |
| BlackRock | 2,357,123 | 7.61% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 2,282,972 | 7.37% | Form 13F, quarter ended March 31, 2024 |
| Wasatch Advisors LP | 1,186,181 | 3.83% | Proxy statement (DEF 14A), proxy filed April 3, 2024 |
| Invesco | 815,801 | 2.63% | Form 13F, quarter ended March 31, 2024 |
| State Street | 696,959 | 2.25% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 532,749 | 1.72% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 510,923 | 1.65% | Form 13F, quarter ended March 31, 2024 |
| D.E. Shaw | 372,079 | 1.20% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 30,983,185 shares outstanding, as reported by MEDPACE HOLDINGS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At MEDPACE HOLDINGS INC.'s shareholder meeting held May 17, 2024, in the 2023-2024 proxy season, 532 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 3,281 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers as disclosed… — MEDPACE HOLDINGS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: MEDPACE HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MEDPACE HOLDINGS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
MEDPACE HOLDINGS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “MEDPACE HOLDINGS (MEDP) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/medpace-holdings-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.